The effect of version update in radiotherapy treatment planning system on early-stage glottic laryngeal cancer plans

Nilsu Çini, Beyhan Ceylaner Bıçakçı

DOI: 10.5606/fng.btd.2024.141

Issue: 2024, Volume 10 - Issue 1
2277 1786

Genetically engineered mice models and generating glioblastoma multiforme in the brain

Yasin Polat, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.147

Issue: 2024, Volume 10 - Issue 1
2910 1967

Microbial influences on cancer: Mechanisms and implications

Gökçen Kılınç, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.161

Issue: 2024, Volume 10 - Issue 3
3188 1093

Expression profiles and regulatory crosstalk of lncRNA HOTAIR and miR-29b-3p across breast cancer subtypes: Implications for tumor progression and therapy resistance

Şara Alagöz, Şehnaz Doğa Kök

DOI: 10.5606/fng.btd.2025.189

Issue: 2025, Volume 11 - Issue 2
913 699

The ZEB1-AS1/ZEB1 axis promotes epithelial-mesenchymal transition in prostate cancer

Gamze Nur Öter, Merve Nur Işık Kolukısaoğlu, İlknur Bingül, Servet Tunoğlu, Canan Küçükgergin

DOI: 10.5606/fng.btd.2025.192

Issue: 2025, Volume 11 - Issue 2
679 596

The role of mesenchymal stem cell exosomes in cancer biology

Alper Demirezen

DOI: 10.5606/fng.btd.2025.186

Issue: 2025, Volume 11 - Issue 2
784 592

Subtype-specific lncRNA signatures: MALAT1 and XIST in breast cancer

Pelin Soytürk, Miray Acer

DOI: 10.5606/fng.btd.2025.206

Issue: 2025, Volume 11 - Issue 3
20 60

Ferroptosis-related gene regulation and miRNA/lncRNA Network on Temozolomide Resistance in Glioblastoma

Ece Gumusoglu-Acar, Tuba Gunel

DOI: 10.5606/fng.btd.2025.210

Issue: 2025, Volume 11 - Issue 3
11 71

Exosomes in cancer progression: Orchestrators of EMT, pre-metastatic niches, and therapy resistance

Irem Yalim Camci, Arzu Aysan, Nursah Ersezen, Iremnur Caglayan

DOI: 10.5606/fng.btd.2025.199

Issue: 2025, Volume 11 - Issue 3
7 45